Diomed Holdings, Inc. to Present at Jefferies Life Sciences Conference
June 16 2006 - 11:20AM
Business Wire
Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer
of minimally-invasive medical technologies, including its patented
EndoVenous Laser Treatment (EVLT(R)) for varicose veins, today
announced that it will be presenting an overview of the Company's
business at the upcoming Jefferies Life Science Conference at the
Mandarin Oriental Hotel in New York on Tuesday, June 27, 2006 at
3:00 p.m. EST. "Diomed is extremely pleased to be included the
Jefferies Life Sciences Conference," stated James Wylie, President
and Chief Executive Officer for Diomed. "This forum will provide us
with the opportunity to showcase Diomed's market leadership
position in the field of superficial venous disease treatment." Mr.
Wylie will present an overview of the company at 3:00 p.m. EST
Monday, June 27, 2006. To take part in this webcast presentation,
please login at either http://ir.diomedinc.com or
http://www.wsw.com/webcast/jeff11/dio/ . About Jefferies Jefferies,
a global investment bank and institutional securities firm, has
served growing and mid-sized companies and their investors for over
40 years. Headquartered in New York, with more than 25 offices
around the world, Jefferies provides clients with capital markets
and financial advisory services, institutional brokerage,
securities research and asset management. The firm is a leading
provider of trade execution in equity, high yield, convertible and
international securities for institutional investors and high net
worth individuals. Jefferies & Company, Inc. is the principal
operating subsidiary of Jefferies Group, Inc. (NYSE:JEF;
www.jefferies.com). About Diomed Diomed develops and commercializes
minimal and micro-invasive medical procedures that use its
proprietary laser technologies and disposable products. Diomed's
EVLT(R) laser vein ablation procedure is used in varicose vein
treatments. Diomed also provides photodynamic therapy (PDT) for use
in cancer treatments, and dental and general surgical applications.
The EVLT(R) procedure and the Company's related products were
cleared by the United States FDA in January of 2002. Along with
lasers and single-use procedure kits for its EVLT(R) laser vein
treatment, the Company provides its customers with state of the art
physician training and practice development support. Additional
information is available on the Company's website: www.evlt.com.
EVLT(R) is a registered trademark of Diomed Inc., Andover, MA.
Diomed (AMEX:DIO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Diomed (AMEX:DIO)
Historical Stock Chart
From Jul 2023 to Jul 2024